OssDsign AB (publ) (OSSD.ST) Research

OssDsign AB (publ) specializes in the innovation, manufacturing, and distribution of advanced implant and material technologies crucial for bone regeneration. The company operates across a broad international market, including Sweden, Germany, the United States, the United Kingdom, the wider European region, and other global territories. Its product line features OSSDSIGN cranial, a comprehensive implant and accessory system engineered for the reconstruction of skull defects in cranioplasty procedures. Another key offering, OSSDSIGN facial, is designed to correct skeletal deformities, whether they arise from trauma or are congenital. Additionally, OssDsign provides the OSSDSIGN Cranioplug, which serves to secure bone flaps and cover burr holes, and OssDsign Catalyst, a cutting-edge nanosynthetic bone graft substitute specifically formulated to stimulate healthy bone tissue formation. Established in 2011, the company maintains its primary operational base in Uppsala, Sweden.

Market snapshot

Symbol
OSSD.ST
Price
$4.14
Day change
-1.31%
Market cap
$458.0M
P/E ratio
-9.15x
52-week range
3.335-16.72
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • BICO Group AB (publ) (BICO.ST)
  • C-Rad AB (publ) (CRAD-B.ST)
  • Diamyd Medical AB (publ) (DMYD-B.ST)
  • Genovis AB (publ.) (GENO.ST)
  • Oncopeptides AB (publ) (ONCO.ST)
  • Paxman AB (publ) (PAX.ST)
  • Sedana Medical AB (publ) (SEDANA.ST)
  • Senzime AB (publ) (SEZI.ST)

Open OssDsign AB (publ) (OSSD.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.